Notes

Three Of The Biggest Catastrophes In ADHD Medication Pregnancy History
ADHD Medication During Pregnancy and Breastfeeding

The decision to stop or keep ADHD medications during breastfeeding and pregnancy is challenging for women with the condition. There is a lack of information about how long-term exposure to these medications may affect the fetus.

A study recently published in Molecular Psychiatry shows that children exposed to ADHD medication during the uterus don't develop neurological developmental disorders such as impaired vision or hearing seizures, febrile seizures, or IQ impairment. The authors acknowledge the need for higher-quality studies.

Risk/Benefit Analysis

Pregnant women who take ADHD medications must weigh the benefits of using them against the risks to the foetus. Physicians don't have the data to provide clear recommendations however they can provide information about risks and benefits to help pregnant women make an informed decision.

A study published in Molecular Psychiatry concluded that women who were taking ADHD medication during early pregnancy were not at higher risk of fetal malformations, or structural birth defects. Researchers conducted a large population-based study of case control to compare the incidence of structural defects that were major in infants who were born to mothers who took stimulants during pregnancy. Clinical geneticists, pediatric cardiologists and other experts looked over the cases to make sure that the classification was correct and to reduce any bias.

However, the researchers' study had its limitations. The most important issue was that they were unable to separate the effects of the medication from the underlying disorder. That limitation makes it difficult to know whether the small differences observed in the groups that were exposed are due to the use of medication or comorbidities that cause confusion. The researchers did not examine long-term outcomes for the offspring.

The study revealed that infants whose mother took ADHD medication during pregnancy had a slightly greater risk of being admitted to the neonatal care unit (NICU), compared to mothers who did not take any medication during pregnancy or had discontinued taking their medication prior to or during pregnancy. This was due to central nervous system disorders. The higher risk of admission was not affected by the stimulant medication that was used during pregnancy.

Women who were taking stimulant ADHD medications during pregnancy also had a higher risk of having to have an emergency caesarean section or having one whose baby scored low on the Apgar scale (less than 7). These risks did not appear to be influenced by the kind of medication used during pregnancy.

adhd depression medication suggest that the small risks posed by the use of ADHD medication during pregnancies in the early stages could be offset by the greater benefits to both mother and baby from continuing treatment for the woman's condition. Physicians should discuss the issue with their patients and, where they are able, assist them in developing strategies to improve their coping abilities which can reduce the effects of her disorder on her daily life and relationships.

Interactions with Medication

More and more doctors are confronted with the dilemma of whether to continue treatment or stop as more women are diagnosed with ADHD. Most of the time, these decisions are made in the absence of clear and authoritative evidence either way, so physicians must weigh what they know from their own experiences, those of other doctors, and what the research suggests on the subject and their own best judgment for each individual patient.

The issue of possible risks to infants is extremely difficult. The research that has been conducted on this topic is based on observations instead of controlled studies and the results are contradictory. Most studies restrict their analysis to live births, which can underestimate the severity of teratogenic effects leading to abortions or terminations of pregnancy. The study that is discussed in this journal club addresses these issues by examining data on both live and deceased births.

Conclusion Some studies have revealed a positive correlation between ADHD medications and certain birth defects However, other studies haven't shown such a relationship. The majority of studies show that there is a neutral, or slightly negative, impact. As a result an accurate risk-benefit analysis is required in every instance.


For many women with ADHD, the decision to stop taking medication is difficult, if not impossible. In fact, in an article published in the Archives of Women's Mental Health psychologist Jennifer Russell notes that stopping ADHD medication during pregnancy can cause depression, feelings of isolation, and family conflict for those suffering from the disorder. In addition, a decrease in medication may affect the ability to do job-related tasks and drive safely which are essential aspects of daily life for a lot of people with ADHD.

She suggests that women who are unsure whether to continue taking the medication or discontinue it due to pregnancy should educate family members, coworkers and acquaintances about the condition, its effects on daily functioning, and the advantages of staying on the current treatment. It will also help a woman feel more confident in her decision. It is also worth noting that certain medications are able to pass through the placenta, so if the patient decides to stop taking her ADHD medication during pregnancy and breastfeeding, she must be aware of the possibility that traces of the medication could be transferred to the infant.

Birth Defects Risk

As the use and abuse of ADHD drugs to treat symptoms of attention deficit hyperactivity disorder (ADHD), increases as does the concern about the potential adverse effects of the drugs on foetuses. A recent study published in the journal Molecular Psychiatry adds to the existing knowledge on this subject. With two massive data sets researchers were able examine more than 4.3 million pregnancies to determine whether the use of stimulant medications increased the risk of birth defects. While the overall risk remains low, the scientists found that exposure in the first trimester to ADHD medications was linked to an increased risk of certain heart defects like ventriculo-septal defects (VSD).

The authors of the study didn't find any association between early medication usage and other congenital anomalies, such as facial deformities or club feet. The results are in line with previous studies showing the presence of a small, but significant increase in the risk of cardiac malformations among women who began taking ADHD medications prior to the time of the birth of their child. This risk increased during the latter part of pregnancy, when a lot of women decide to stop taking their medication.

Women who took ADHD medication during the first trimester were more likely to need a caesarean and also have an insufficient Apgar after birth and have a baby that needed breathing assistance at birth. However, the authors of the study were unable to eliminate bias due to selection by restricting the study to women who did not have any other medical conditions that could be a contributing factor to these findings.

Researchers hope that their research will help doctors when they see pregnant women. The researchers advise that while discussing the risks and benefits are important, the decision regarding whether or not to stop medication should be made in light of the severity of each woman's ADHD symptoms and her needs.

The authors also advise that even though stopping the medication is an alternative, it is not a recommended practice because of the high incidence of depression and other mental health issues among women who are pregnant or recently postpartum. Further, the research suggests that women who choose to stop their medications are more likely to experience a difficult time adjusting to life without them following the baby's arrival.

Nursing

The responsibilities of being a new mother can be overwhelming. Women with ADHD who have to deal with their symptoms while attending physician appointments, making preparations for the arrival of a child and getting used to new routines at home can experience severe challenges. Many women decide to continue taking their ADHD medication during pregnancy.

The majority of stimulant medications are absorbed through breast milk in low amounts, therefore the risk for nursing infant is very low. However, the rate of exposure to medications by the infant can differ based on dosage, how often it is administered, and the time of the day it is administered. Additionally, individual medications enter the body of the baby differently through the gastrointestinal tract as well as breast milk and the impact of this on a newborn isn't fully known.

Some doctors may decide to stop stimulant medication during a woman’s pregnancy due to the lack of research. This is a difficult choice for the patient, who must weigh the benefits of continuing her medication with the potential risks to the foetus. Until more information is available, doctors should ask all pregnant patients about their experience with ADHD and if they plan or are taking to take medication during the perinatal period.

A increasing number of studies have shown that women can continue to take their ADHD medication during pregnancy and breastfeeding. In response, an increasing number of patients are opting to continue their medication. They have found through consultation with their doctor that the benefits of continuing their current medication far outweigh any risk.

Women with ADHD who are planning to nurse should seek advice from a specialist psychiatrist prior to becoming pregnant. They should discuss their medication with their doctor and discuss the pros and cons of continued treatment, including non-pharmacological strategies. Psychoeducation is also needed to help pregnant women suffering from ADHD understand the symptoms and underlying disorder. They should also be educated about treatment options and reinforce strategies for coping. This should be an approach that is multidisciplinary, including the GP doctors, obstetricians and psychiatrists. Pregnancy counseling should include discussion of a treatment plan for the mother and the child, monitoring of indicators of deterioration, and, if necessary modifications to the medication regimen.

My Website: https://www.iampsychiatry.uk/adult-adhd-medication/